150 related articles for article (PubMed ID: 37484385)
1. The sub-molecular characterization identification for cervical cancer.
Mo X; Wang N; He Z; Kang W; Wang L; Han X; Yang L
Heliyon; 2023 Jun; 9(6):e16873. PubMed ID: 37484385
[TBL] [Abstract][Full Text] [Related]
2. Identification of immune related molecular subtypes and prognosis model for predicting prognosis, drug resistance in cervical squamous cell carcinoma.
Hu D; Zhang Z; Zhang Y; Huang K; Li X
Front Genet; 2023; 14():1137995. PubMed ID: 37007965
[No Abstract] [Full Text] [Related]
3. A Novel Prognostic Risk Model for Cervical Cancer Based on Immune Checkpoint HLA-G-Driven Differentially Expressed Genes.
Xu HH; Wang HL; Xing TJ; Wang XQ
Front Immunol; 2022; 13():851622. PubMed ID: 35924232
[TBL] [Abstract][Full Text] [Related]
4. High Expression of TMEM33 Predicts Poor Prognosis and Promotes Cell Proliferation in Cervical Cancer.
Chen H; Zhao X; Li Y; Zhang S; Wang Y; Wang L; Ma W
Front Genet; 2022; 13():908807. PubMed ID: 35832191
[No Abstract] [Full Text] [Related]
5. Ferroptosis-related genes identify tumor immune microenvironment characterization for the prediction of prognosis in cervical cancer.
Yang X; Yin F; Liu Q; Ma Y; Zhang H; Guo P; Wen W; Guo X; Wu Y; Yang Z; Han Y
Ann Transl Med; 2022 Jan; 10(2):123. PubMed ID: 35282071
[TBL] [Abstract][Full Text] [Related]
6. TPM3: a novel prognostic biomarker of cervical cancer that correlates with immune infiltration and promotes malignant behavior
Zhao YC; Wang TJ; Qu GH; She LZ; Cui J; Zhang RF; Qu HD
Am J Cancer Res; 2023; 13(7):3123-3139. PubMed ID: 37559998
[TBL] [Abstract][Full Text] [Related]
7. Gene signatures, immune infiltration, and drug sensitivity based on a comprehensive analysis of m6a RNA methylation regulators in cervical cancer.
Lu X; Li R; Ying Y; Zhang W; Wang W
J Transl Med; 2022 Sep; 20(1):385. PubMed ID: 36058934
[TBL] [Abstract][Full Text] [Related]
8. Identification of a necroptosis-related prognostic gene signature associated with tumor immune microenvironment in cervical carcinoma and experimental verification.
Sun K; Huang C; Li JZ; Luo ZX
World J Surg Oncol; 2022 Oct; 20(1):342. PubMed ID: 36253777
[TBL] [Abstract][Full Text] [Related]
9. Identification of a tumor microenvironment-related gene signature to improve the prediction of cervical cancer prognosis.
Chen Q; Qiu B; Zeng X; Hu L; Huang D; Chen K; Qiu X
Cancer Cell Int; 2021 Mar; 21(1):182. PubMed ID: 33766042
[TBL] [Abstract][Full Text] [Related]
10. The immune landscape and prognostic analysis of CXCL8 immune-related genes in cervical squamous cell carcinoma.
Zhang X; Yang J; Feng Q; Gu L; Qin G; Cheng C; Hou S; Shi Z
Environ Toxicol; 2024 Apr; ():. PubMed ID: 38597597
[TBL] [Abstract][Full Text] [Related]
11. Effects of miR-202-5p silencing PIK3CA gene expression on proliferation, invasion, and epithelial-mesenchymal transition of cervical cancer SiHa cells through inhibiting PI3K/Akt/mTOR signaling pathway activation.
Zheng Y; Xie L; Xu S; Yan W; Zhang H; Meng Y; Liu J; Wei X
Mol Cell Biochem; 2021 Nov; 476(11):4031-4044. PubMed ID: 34244973
[TBL] [Abstract][Full Text] [Related]
12. Exploration of a Robust and Prognostic Immune Related Gene Signature for Cervical Squamous Cell Carcinoma.
Zuo Z; Xiong J; Zeng C; Jiang Y; Xiong K; Tao H; Guo Y
Front Mol Biosci; 2021; 8():625470. PubMed ID: 33748188
[No Abstract] [Full Text] [Related]
13. Construction of an HLA Classifier for Early Diagnosis, Prognosis, and Recognition of Immunosuppression in Sepsis by Multiple Transcriptome Datasets.
Chen Z; Chen R; Ou Y; Lu J; Jiang Q; Liu G; Wang L; Liu Y; Zhou Z; Yang B; Zuo L
Front Physiol; 2022; 13():870657. PubMed ID: 35685286
[No Abstract] [Full Text] [Related]
14. Effects of RNA Modification "Writers" of GALNT2 on the Tumor Microenvironment in Cervical Squamous Cell Carcinoma.
Wang S; Chen L
J Environ Pathol Toxicol Oncol; 2022; 41(4):25-38. PubMed ID: 36374960
[TBL] [Abstract][Full Text] [Related]
15. Construction and validation of prognostic prediction established on N6-methyladenosine related genes in cervical squamous cell carcinoma.
Chen D; Guo W; Yu H; Yang J
Transl Cancer Res; 2022 Sep; 11(9):3064-3079. PubMed ID: 36237271
[TBL] [Abstract][Full Text] [Related]
16. Decreased expression of CLCA2 and the correlating with immune infiltrates in patients with cervical squamous cell carcinoma: A bioinformatics analysis.
Yang X; Cao JL; Yang FN; Li XF; Tao LM; Wang F
Taiwan J Obstet Gynecol; 2021 May; 60(3):480-486. PubMed ID: 33966732
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Value and Immune Infiltration of HPV-Related Genes in the Immune Microenvironment of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma.
Gan Q; Mao L; Shi R; Chang L; Wang G; Cheng J; Chen R
Cancers (Basel); 2023 Feb; 15(5):. PubMed ID: 36900213
[TBL] [Abstract][Full Text] [Related]
18. Hsa_circ_0072008 regulates cell proliferation, migration, and invasion in cervical squamous cell carcinoma via miR-1305/helicase, lymphoid specific (HELLS) axis.
He C; Liu L
Bioengineered; 2022 Apr; 13(4):8311-8322. PubMed ID: 35311456
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive analysis of clinical prognosis and biological significance of CNIH4 in cervical cancer.
Wang J; Wang S; Wang J; Huang J; Lu H; Pan B; Pan H; Song Y; Deng Q; Jin X; Shi G
Cancer Med; 2023 Dec; 12(24):22381-22394. PubMed ID: 38087815
[TBL] [Abstract][Full Text] [Related]
20. Identification of Stemness-Related Genes for Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma by Integrated Bioinformatics Analysis.
Guo H; Wang S; Ju M; Yan P; Sun W; Li Z; Wu S; Lin R; Xian S; Yang D; Wang J; Huang Z
Front Cell Dev Biol; 2021; 9():642724. PubMed ID: 33842467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]